Examination of the efficacy of Chlormadinone Acetate on the Dutasteride resistance Benign Prostatic Hyperplasia.
Not Applicable
- Conditions
- Benign Prostatic Hyperplasia
- Registration Number
- JPRN-UMIN000010628
- Lead Sponsor
- Kobe University Graduate of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with suspected prostate cancer by PSA or DRE. 2)Patients with suspected Neurogenic Bladder. 3)Patients with urethral stricture. 4)Patients who gave radiotherapy in the pelvis. 5)Patients with chronic urinary tract infection, active cystitis interstitial. 6)Patients with serious liver damage / liver disease. 7)Patients with heart disease, renal disease or Anamnesis. 8)Diabetic 9)Patients was deemed by the physician as inappropriate to attend.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction rate of Prostate Volume
- Secondary Outcome Measures
Name Time Method International Prostatic Symptom Score (I-PSS), QOL-Score, maximum urinary flow rate, residual urine volume, blood test(AST, ALT, blood glucose), Adversed Event, tumor marker(serum PSA), free Testosterone